Tumor-related epilepsy: epidemiology, pathogenesis and management

J Neurooncol. 2018 Aug;139(1):13-21. doi: 10.1007/s11060-018-2862-0. Epub 2018 May 24.

Abstract

Introduction: Seizure is a common comorbidity in patients with brain tumor. It may be the presenting symptom or develop after the tumor diagnosis. The underlying pathophysiology of brain tumor-related epilepsy remains poorly understood.

Methods: A comprehensive literature review of Pubmed English articles from 1980-2017 was performed to summarize current knowledge and treatment options of brain tumor-related epilepsy.

Results: Multiple factors have been found to contribute to tumor-related epilepsy, including tumor type, speed of tumor growth, location, and tumor burden. The underlying pathogenesis of epilepsy is not clear but perturbations in the peri-tumoral regions, both structural and cellular communications, have been implicated.

Conclusions: Surgical and medical treatments of tumor-related epilepsy remain challenging as additional factors such as the extent of surgical resection, interactions with tumor-related oncological treatments and anti-epileptic medication related side effects need to be considered.

Keywords: Anti-epileptics; Brain tumor; Epilepsy; Pathophysiology; Tumor-associated epilepsy.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / complications*
  • Brain Neoplasms / epidemiology
  • Brain Neoplasms / physiopathology
  • Brain Neoplasms / therapy*
  • Epilepsy / epidemiology
  • Epilepsy / etiology*
  • Epilepsy / physiopathology
  • Epilepsy / therapy*
  • Humans